Association of sex, age, and comorbidities with mortality in COVID-19 patients: a systematic review and meta-analysis
Introduction: Although severe acute respiratory syndrome coronavirus-2 infection is causing
mortality in considerable proportion of coronavirus disease-2019 (COVID-19) patients …
mortality in considerable proportion of coronavirus disease-2019 (COVID-19) patients …
Pathophysiological mechanisms of liver injury in COVID‐19
AD Nardo, M Schneeweiss‐Gleixner… - Liver …, 2021 - Wiley Online Library
The recent outbreak of coronavirus disease 2019 (COVID‐19), caused by the Severe Acute
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …
Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) has resulted in a world‐wide …
Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature
Introduction On February 11, 2020 WHO designated the name “COVID-19” for the disease
caused by “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus …
caused by “severe acute respiratory syndrome coronavirus 2”(SARS-CoV-2), a novel virus …
Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis
X Li, X Zhong, Y Wang, X Zeng, T Luo, Q Liu - PloS one, 2021 - journals.plos.org
Objective We aimed to systematically identify the possible risk factors responsible for severe
cases. Methods We searched PubMed, Embase, Web of science and Cochrane Library for …
cases. Methods We searched PubMed, Embase, Web of science and Cochrane Library for …
Abnormal liver function tests in patients with COVID‐19: relevance and potential pathogenesis
Lipopolysaccharide Reverses Hepatic Stellate Cell Activation... : Hepatology Lipopolysaccharide
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against …
COVID–19 and chronic kidney disease: an updated overview of reviews
Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …
Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry
D Giannis, SL Allen, J Tsang, S Flint… - Blood, The Journal …, 2021 - ashpublications.org
Thromboembolic events, including venous thromboembolism (VTE) and arterial
thromboembolism (ATE), and mortality from subclinical thrombotic events occur frequently in …
thromboembolism (ATE), and mortality from subclinical thrombotic events occur frequently in …
Systematic review with meta‐analysis: liver manifestations and outcomes in COVID‐19
AV Kulkarni, P Kumar, HV Tevethia… - Alimentary …, 2020 - Wiley Online Library
Background The incidence of elevated liver chemistries and the presence of pre‐existing
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …
chronic liver disease (CLD) have been variably reported in COVID‐19. Aims To assess the …
Covid-19 and non-communicable diseases: evidence from a systematic literature review
Z Nikoloski, AM Alqunaibet, RA Alfawaz… - BMC Public Health, 2021 - Springer
Abstract Background Since early 2020, the Covid-19 pandemic has engulfed the world.
Amidst the growing number of infections and deaths, there has been an emphasis of …
Amidst the growing number of infections and deaths, there has been an emphasis of …
Prevalence of chronic liver disease in patients with COVID-19 and their clinical outcomes: a systematic review and meta-analysis
Abnormal liver enzymes are seen in 20% of hospitalized patients with COVID-19. The
etiology of elevated liver enzymes is thought to be multifactorial including medications and …
etiology of elevated liver enzymes is thought to be multifactorial including medications and …